🔴 MDxHealth is trading 7% down — no clear catalyst identified

MDxHealth is trading at $0.18 (-7.06%) on October 28, 2026, with no clear company-specific catalyst identified.

• On October 15, the company preliminarily expected third-quarter revenue of $22.7 million, flat year over year, and suspended its $110–115 million full-year revenue guidance.
• Analyst downgrades followed the revenue shortfall, but available sources do not establish the earlier news or downgrades as the direct cause of this session’s decline. The broader market was nearly flat and does not clearly explain the drop.